Filing Flows › Bristol Myers Squibb (BMY) › Free cash flow
Bristol Myers Squibb (BMY) free cash flow by quarter
Bristol Myers Squibb's free cash flow was $3.8B in Q3 2026 (third quarter 2026), +24% from Q2 2026. Over the last 7 quarters it ranged from $757M (Q1 2026) to $6.0B (Q3 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.8B | +24% | -36% |
| Q2 2026 | $3.1B | +308% | -13% |
| Q1 2026 | $757M | -53% | -55% |
| Q4 2025 | $1.6B | -73% | — |
| Q3 2025 | $6.0B | +68% | — |
| Q2 2025 | $3.6B | +110% | — |
| Q1 2025 | $1.7B | — | — |
Q3 2026 at a glance
Bristol Myers Squibb, Q3 2026: revenue $13.1B (+7% year over year), operating margin 19.4%, net earnings $2.2B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
Questions
What is Bristol Myers Squibb's free cash flow?
Bristol Myers Squibb's free cash flow was $3.8B in Q3 2026 (third quarter 2026), +24% from Q2 2026.
How has Bristol Myers Squibb's free cash flow changed?
Over the last 7 quarters it ranged from $757M (Q1 2026) to $6.0B (Q3 2025).